Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor.

Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B, Yarden Y.

Genes Dev. 1998 Dec 1;12(23):3663-74.

2.

The Grb7 family of signalling proteins.

Daly RJ.

Cell Signal. 1998 Oct;10(9):613-8. Review.

PMID:
9794242
3.

Increasing complexity of Ras signaling.

Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ.

Oncogene. 1998 Sep 17;17(11 Reviews):1395-413. Review.

4.

NRG-3 in human breast cancers: activation of multiple erbB family proteins.

Hijazi MM, Young PE, Dougherty MK, Bressette DS, Cao TT, Pierce JH, Wong LM, Alimandi M, King CR.

Int J Oncol. 1998 Nov;13(5):1061-7.

PMID:
9772300
5.

Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation.

Coffer PJ, Jin J, Woodgett JR.

Biochem J. 1998 Oct 1;335 ( Pt 1):1-13. Review.

6.

Cbl: complex formation and functional implications.

Liu YC, Altman A.

Cell Signal. 1998 Jun;10(6):377-85. Review.

PMID:
9720760
8.

ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner.

Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B, Hynes NE.

Mol Cell Biol. 1998 Sep;18(9):5042-51.

9.

Switching signals on or off by receptor dimerization.

Weiss A, Schlessinger J.

Cell. 1998 Aug 7;94(3):277-80. Review. No abstract available.

11.

Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.

Lenferink AE, Pinkas-Kramarski R, van de Poll ML, van Vugt MJ, Klapper LN, Tzahar E, Waterman H, Sela M, van Zoelen EJ, Yarden Y.

EMBO J. 1998 Jun 15;17(12):3385-97.

12.

ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.

Wang LM, Kuo A, Alimandi M, Veri MC, Lee CC, Kapoor V, Ellmore N, Chen XH, Pierce JH.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6809-14.

13.

The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.

Miyake S, Lupher ML Jr, Andoniou CE, Lill NL, Ota S, Douillard P, Rao N, Band H.

Crit Rev Oncog. 1997;8(2-3):189-218. Review.

PMID:
9570294
14.

Synthetic activation of caspases: artificial death switches.

MacCorkle RA, Freeman KW, Spencer DM.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3655-60.

15.

Specificity within the EGF family/ErbB receptor family signaling network.

Riese DJ 2nd, Stern DF.

Bioessays. 1998 Jan;20(1):41-8. Review.

PMID:
9504046
16.

Small-molecule control of insulin and PDGF receptor signaling and the role of membrane attachment.

Yang J, Symes K, Mercola M, Schreiber SL.

Curr Biol. 1998 Jan 1;8(1):11-8.

17.

A versatile synthetic dimerizer for the regulation of protein-protein interactions.

Amara JF, Clackson T, Rivera VM, Guo T, Keenan T, Natesan S, Pollock R, Yang W, Courage NL, Holt DA, Gilman M.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10618-23.

18.
19.

Role of c-Src tyrosine kinase in EGF-induced mitogenesis.

Belsches AP, Haskell MD, Parsons SJ.

Front Biosci. 1997 Oct 15;2:d501-18. Review.

Items per page

Supplemental Content

Write to the Help Desk